Genomic characterization of advanced and recurrent endometrial carcinoma: KRAS and TP53 co-mutation as a biomarker for adverse prognosis and therapeutic failure

Gynecologic Oncology · Elsevier

Аннотация

Publication date: November 2026 Source: Gynecologic Oncology, Volume 214 Author(s): Sanghoo Lee, Kyeong-A So, Soyeon Kim, Mi-Kyeong Lee, Yun Hwan Kim, Tae Jin Kim, Mi-Kyung Kim

Читать у издателя →

Похожие статьи